Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
S-303 Red Blood Cells - Test · 1 trial · 1 indication
The mean hemoglobin content per red blood cell (RBC) component compared between the treatment groups
The frequency of adverse events (related and unrelated to study RBC components) will be compared between the treatment groups.
| Arm | Type | Description |
|---|---|---|
| S-303 Treated Red Blood Cells | EXPERIMENTAL | Patients receive S-303 treated red blood cells (RBCs). |
| Conventional, untreated Red Blood Cells | ACTIVE_COMPARATOR | Patients receive conventional, untreated red blood cells (RBCs). |
| Name | Type | Description |
|---|---|---|
| S-303 Red Blood Cells (RBCs) - Test | BIOLOGICAL | - |
| Conventional, untreated red blood cells (RBCs) - Control | BIOLOGICAL | - |
Inclusion Criteria: 1. Age ≥18 years, of either gender. 2. Must be willing to use an acceptable form of contraceptive while on study (as approved by the Investigator or designee) 3. Must be readily available by telephone 4. Must provide an informed consent for study participation and have signed an...